Lung Cancer Trials Ask AI to find trials
TerminatedNot applicableNCT00205439
Official study title

Surveillance For New Lung Primaries

Study summary

The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic surveillance may help to define the natural history of these lesions and allow earlier intervention should they progress to invasive lesions.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 15, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Wisconsin, Madison

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Wisconsin, Madison
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

History squamous cell NSCLC who have undergone complete resection or definitive chemotherapy

Reasons someone may not be able to joinExclusion criteria
  • History of an aerodigestive tract carcinoma of non-squamous histology
  • Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have undergone resection or chemotherapy within three years
  • Patients who have Stage I or II squamous cell lung cancer that have undergone resection or chemotherapy within one year
  • Patients who have received external beam radiation therapy for treatment of a squamous cell cancer of the lung

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Wisconsin Hospital and ClinicsMadison, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 15, 2019. Always confirm current availability with the study team.

View original record ↗